AUTHOR'S PROFILE

Gerlach

Publications (18)

Explainable time-to-progression predictions in multiple sclerosis.

Journal: Computer methods and programs in biomedicine

Publication Year: 

Authors & Co-authors:  D'hondt Robbe R Dedja Klest K Aerts Sofie S Van Wijmeersch Bart B Kalincik Tomas T Reddel Stephen S Havrdova Eva Kubala EK Lugaresi Alessandra A Weinstock-Guttman Bianca B Mrabet Saloua S

Disease Activity in Pregnant and Postpartum Women With Multiple Sclerosis Receiving Ocrelizumab or Other Disease-Modifying Therapies.

Journal: Neurology(R) neuroimmunology & neuroinflammation

Publication Year: 2024

Authors & Co-authors:  Yeh Wei Z WZ Van Der Walt Anneke A Skibina Olga G OG Kalincik Tomas T Alroughani Raed R Kermode Allan G AG Fabis-Pedrini Marzena J MJ Carroll William M WM Lechner-Scott Jeannette J Boz Cavit C

Disease Activity in Pregnant and Postpartum Women With Multiple Sclerosis Receiving Ocrelizumab or Other Disease-Modifying Therapies.

Journal: Neurology(R) neuroimmunology & neuroinflammation

Publication Year: 2024

Authors & Co-authors:  Yeh Wei Z WZ Van Der Walt Anneke A Skibina Olga G OG Kalincik Tomas T Alroughani Raed R Kermode Allan G AG Fabis-Pedrini Marzena J MJ Carroll William M WM Lechner-Scott Jeannette J Boz Cavit C

Machine-learning-based prediction of disability progression in multiple sclerosis: An observational, international, multi-center study.

Journal: PLOS digital health

Publication Year: 

Authors & Co-authors:  De Brouwer Edward E Becker Thijs T Werthen-Brabants Lorin L Dewulf Pieter P Iliadis Dimitrios D Dekeyser Cathérine C Laureys Guy G Van Wijmeersch Bart B Popescu Veronica V Dhaene Tom T

Longitudinal determinants of employment status in people with relapsing-remitting multiple sclerosis.

Journal: IBRO neuroscience reports

Publication Year: 

Authors & Co-authors:  van Egmond E E A EEA van der Hiele K K de Rooij M J MJ van Gorp D A M DAM Jongen P J PJ van der Klink J J L JJL Reneman M F MF Beenakker E A C EAC van Eijk J J J JJJ Frequin S T F M STFM

Heterogeneity on long-term disability trajectories in patients with secondary progressive MS: a latent class analysis from Big MS Data network.

Journal: Journal of neurology, neurosurgery, and psychiatry

Publication Year: 2022

Authors & Co-authors:  Signori Alessio A Lorscheider Johannes J Vukusic Sandra S Trojano Maria M Iaffaldano Pietro P Hillert Jan J Hyde Robert R Pellegrini Fabio F Magyari Melinda M Koch-Henriksen Nils N

Comparative effectiveness in multiple sclerosis: A methodological comparison.

Journal: Multiple sclerosis (Houndmills, Basingstoke, England)

Publication Year: 2023

Authors & Co-authors:  Roos Izanne I Diouf Ibrahima I Sharmin Sifat S Horakova Dana D Havrdova Eva Kubala EK Patti Francesco F Shaygannejad Vahid V Ozakbas Serkan S Izquierdo Guillermo G Eichau Sara S

Early non-disabling relapses are important predictors of disability accumulation in people with relapsing-remitting multiple sclerosis.

Journal: Multiple sclerosis (Houndmills, Basingstoke, England)

Publication Year: 2023

Authors & Co-authors:  Daruwalla Cyrus C Shaygannejad Vahid V Ozakbas Serkan S Havrdova Eva Kubala EK Horakova Dana D Alroughani Raed R Boz Cavit C Patti Francesco F Onofrj Marco M Lugaresi Alessandra A

The risk of secondary progressive multiple sclerosis is geographically determined but modifiable.

Journal: Brain : a journal of neurology

Publication Year: 2023

Authors & Co-authors:  Sharmin Sifat S Roos Izanne I Simpson-Yap Steve S Malpas Charles C Sánchez Marina M MM Ozakbas Serkan S Horakova Dana D Havrdova Eva K EK Patti Francesco F Alroughani Raed R

Effectiveness of multiple disease-modifying therapies in relapsing-remitting multiple sclerosis: causal inference to emulate a multiarm randomised trial.

Journal: Journal of neurology, neurosurgery, and psychiatry

Publication Year: 2023

Authors & Co-authors:  Diouf Ibrahima I Malpas Charles B CB Sharmin Sifat S Roos Izanne I Horakova Dana D Kubala Havrdova Eva E Patti Francesco F Shaygannejad Vahid V Ozakbas Serkan S Eichau Sara S

Comparative Effectiveness of Autologous Hematopoietic Stem Cell Transplant vs Fingolimod, Natalizumab, and Ocrelizumab in Highly Active Relapsing-Remitting Multiple Sclerosis.

Journal: JAMA neurology

Publication Year: 2023

Authors & Co-authors:  Kalincik Tomas T Sharmin Sifat S Roos Izanne I Freedman Mark S MS Atkins Harold H Burman Joachim J Massey Jennifer J Sutton Ian I Withers Barbara B Macdonell Richard R

Examining the environmental risk factors of progressive-onset and relapsing-onset multiple sclerosis: recruitment challenges, potential bias, and statistical strategies.

Journal: Journal of neurology

Publication Year: 2024

Authors & Co-authors:  Li Ying Y Saul Alice A Taylor Bruce B Ponsonby Anne-Louise AL Simpson-Yap Steve S Blizzard Leigh L Broadley Simon S Lechner-Scott Jeannette J Karabudak Rana R

Comparative effectiveness and cost-effectiveness of natalizumab and fingolimod in rapidly evolving severe relapsing-remitting multiple sclerosis in the United Kingdom.

Journal: Journal of medical economics

Publication Year: 2023

Authors & Co-authors:  Spelman T T Herring W L WL Acosta C C Hyde R R Jokubaitis V G VG Pucci E E Lugaresi A A Laureys G G Havrdova E K EK Horakova D D

Routine CSF parameters as predictors of disease course in multiple sclerosis: an MSBase cohort study.

Journal: Journal of neurology, neurosurgery, and psychiatry

Publication Year: 

Authors & Co-authors:  Dekeyser Cathérine C Hautekeete Matthias M Cambron Melissa M Van Pesch Vincent V Patti Francesco F Kuhle Jens J Khoury Samia S Lechner Scott Jeanette J Gerlach Oliver O Lugaresi Alessandra A

Self-reported work productivity in people with multiple sclerosis and its association with mental and physical health.

Journal: Disability and rehabilitation

Publication Year: 2022

Authors & Co-authors:  van Egmond Elianne E A EEA van Gorp Dennis A M DAM Jongen Peter J PJ van der Klink Jac J L JJL Reneman Michiel F MF Arnoldus Edo P J EPJ Beenakker Ernesto A C EAC van Eijk Jeroen J J JJJ Frequin Stephan T F M STFM Gerlach Oliver H H OHH

Work difficulties in people with multiple sclerosis: The role of anxiety, depression and coping.

Journal: Multiple sclerosis journal - experimental, translational and clinical

Publication Year: 

Authors & Co-authors:  van Egmond Eea E van der Hiele K K van Gorp Dam D Jongen P J PJ van der Klink Jjl J Reneman M F MF Beenakker Eac E van Eijk Jjj J Frequin Stfm S de Gans K K

Effect of CYP2D6 genetic variation on patient-reported symptom improvement and side effects among children and adolescents treated with amphetamines.

Journal: Pharmacogenetics and genomics

Publication Year: 

Authors & Co-authors:  Gerlach Maruf Shaheen McCloud Heintz McAusland Arnold Bousman

The World Federation of ADHD International Consensus Statement: 208 Evidence-based conclusions about the disorder.

Journal: Neuroscience and biobehavioral reviews

Publication Year: 2021

Authors & Co-authors:  Faraone Banaschewski Coghill Zheng Biederman Bellgrove Newcorn Gignac Al Saud Manor